Clinical impact of amyloid PET using 18 F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.

Hiroshi MatsudaKyoji OkitaYumiko MotoiToshiki MizunoManabu IkedaNobuo SanjoKoji MurakamiTaiki KambeToshiki TakayamaKei YamadaTakashi SuehiroKeiko MatsunagaTakanori YokotaUkihide TateishiYoko ShigemotoYukio KimuraEmiko ChibaTakahiro KawashimaYui TomoHisateru TachimoriYuichi KimuraNoriko Sato

Published in: Annals of nuclear medicine (2022)

F-florbetapir PET had a substantial clinical impact on AD and non-AD diagnosis and on patient management by enhancing diagnostic confidence. In addition, the quantitative measures may improve the visual interpretation of amyloid positivity.

Keyphrases

cognitive impairment
pet ct
positron emission tomography
computed tomography
pet imaging
case report
pulmonary embolism
cognitive decline
high resolution